Southport Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EIP
Southport Management's AZN Position: Q4 2017 in Review
Southport Management sold out of AstraZeneca (AZN) in Q4 2017, closing a stake of 10,000 shares — an estimated $678K sold.
Southport Management first reported a position in AZN in Q4 2016 and held it in 2 quarters. The position peaked at $678K in Q3 2017. 503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.
- Southport Management reported no remaining AstraZeneca position as of Q4 2017 after selling out during the quarter.
- Southport Management sold 10,000 AstraZeneca shares in Q4 2017, an estimated $678K.
- Southport Management first reported a position in AstraZeneca in Q4 2016 and held it in 2 quarters.
- Southport Management's AstraZeneca position peaked at $678K in Q3 2017.
- 503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.
Based on Southport Management's 13F filing for Q4 2017, filed 14 Feb 2018.